Skip to main content
OpenTrials
Completed

NCT Number: NCT03160755

Motivation-Audit-Positive Psychology Intervention Study

Specific Aim #1: To identify, through qualitative research, deficits in positive emotional states (e.g., positive affect, optimism) and associated barriers to completing health behaviors, like physical activity and healthy eating, in patients with metabolic syndrome (MetS).

Hypothesis: Participants will be able to complete semi-structured interviews, providing information about their positive emotional states, linking the presence of positive emotions to better adherence to health-related behaviors, and identifying additional barriers (e.g., logistic, motivational) to completing such behaviors.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

About this study

This qualitative interview study will focus on the development of a novel positive psychology (PP) and motivational interviewing (MI) intervention that is adapted for patients with MetS. For this phase, participants will be primary care patients recruited through Massachusetts General Hospital's research opt-in program (Research Options Direct to You [RODY]). We will complete phone interviews with patients (n=20) with MetS within two weeks of enrollment in the study.

In this project, we hope to do the following:

  • Identify, through qualitative research, deficits in positive emotional states in primary care patients with MetS.
  • Examine potential links between positive emotional deficits and impaired health behaviors (low physical activity, unhealthy dietary patterns), as well as links between positive emotional states and successful health behaviors.
  • Identify other barriers to health behavior completion, such as social support and neighborhood resources.
  • Explore strategies to enhance positive emotional states in MetS patients and inquire about the utility of potential PP exercises in these patients.
  • Ask participants for feedback about intervention delivery preferences (e.g., session length, time of day, duration of intervention).
  • Develop a preliminary PP-MI based group intervention using the above information.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Both of the two MetS components most strongly related to MetS outcomes and most sensitive to lifestyle change:
  • elevated abdominal obesity (waist circumference >102 cm in men or >88 cm in women)
  • If waist circumference is not available, body mass index (BMI) will be used as a surrogate measure based on prior research (BMI ≥29.1 kg/m2 for men and 27.2 kg/m2 for women).

AND

  • elevated blood pressure (systolic ≥130 and/or diastolic ≥85 mm Hg or be on blood pressure medication).
  • Plus ≥1 additional MetS component:
  • Serum triglycerides ≥150 mg/dL
  • High-density lipoprotein (HDL) cholesterol <40 mg/dL in men or <50 mg/dL in women
  • Fasting plasma glucose >100mg/dL.
  • Suboptimal physical activity defined as <150 minutes/week moderate intensity activity, which represents less than national-level recommendations.

Exclusion criteria

  • Inability to speak/read English
  • Cognitive deficits impeding ability to participate or provide informed consent (measured by a 6-item screen)
  • Illness likely to lead to death in the next 6 months per PCP
  • Current treatment for cancer, liver, or renal disease
  • Pregnancy
  • Documented severe mental illness (e.g., psychosis, suicidality)
  • No telephone access
  • Inability to be physically active
  • Diabetes or known or suggested cardiac disease, given that this is a primary prevention study.

Treatment and study plan

Primary outcomes

  1. Qualitative Data

    Time frame: Baseline

    Themes related to: health behaviors, barriers to completing health behaviors, positive emotional/cognitive experiences and how these may impact adherence to the MetS health behaviors of interest (primarily physical activity).

Secondary outcomes

  1. Dispositional Optimism

    Time frame: Baseline

    Measured by the Life Orientation Test-Revised (LOT-R)

  2. Positive Affect

    Time frame: Baseline

    Measured using the 10 positive affect items on the Positive and Negative Affect Schedule (PANAS)

  3. Anxiety

    Time frame: Baseline

    Measured by the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)

  4. Depression

    Time frame: Baseline

    Measured by the depression subscale of the Hospital Anxiety and Depression Scale (HADS)

  5. Environmental Barriers and Resources

    Time frame: Baseline

    Measured using the Neighborhood Environment Walkability Scale - Abbreviated (NEWS-A)

  6. Barriers to Physical Activity

    Time frame: Baseline

    Measured using the Barriers to Being Active Quiz

  7. Health Related Quality of Life

    Time frame: Baseline

    Assessed via the Medical Outcomes Study Short Form-12 (SF-12)

  8. Physical Activity

    Time frame: Baseline

    Assessed using the well-validated International Physical Activity Questionnaire-Short Form (IPAQ-SF)

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Official study title

Developing a Group-based Positive Psychology and Physical Activity Intervention in Patients With Metabolic Syndrome: Qualitative Research Phase

Acronym: MAPP-I

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
May 19, 2017
Registry last updated
Aug 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.